Shri Lakhavi Drugs P Ltd - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 1994.
1994 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Shri Lakhavi Drugs P Ltd

Shri Lakhavi Drugs P Ltd, a struck off private limited company, was established on 27 June 1994 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239MH1994PTC079220. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sangeeta Bohra (Director), Ranjeet Lachhiram Dave (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at Devchand Building, 1St Floor, Daulat Nagar, Road No.3, Borivali East,, Mumbai, Maharashtra, 400066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1994PTC079220

  • Registration Number

    079220

  • Incorporation Date

    27 June 1994

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 31 Year, 7 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Shri Lakhavi Drugs P Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shri Lakhavi Drugs P Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shri Lakhavi Drugs P Ltd?
Current Directors
Name Designation Appointment Date Status
Sangeeta Bohra Director 27 Jun 1994 Current
Ranjeet Lachhiram Dave Director 27 Jun 1994 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shri Lakhavi Drugs P.

Enhance accessibility to Shri Lakhavi Drugs P's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Shri Lakhavi Drugs P revenue growth over time
Shri Lakhavi Drugs P profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shri Lakhavi Drugs P?

Unlock access to Shri Lakhavi Drugs P's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Shri Lakhavi Drugs P?

Unlock and access historical data on people associated with Shri Lakhavi Drugs P, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shri Lakhavi Drugs P, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Lakhavi Drugs P's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shri Lakhavi Drugs P
Recent Activity within the Organization
  • Annual General Meeting

    The activity Shri Lakhavi Drugs P Ltd last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Shri Lakhavi Drugs P Ltd has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Sangeeta Bohra was appointed as a Director was appointed as a Director on 27 Jun 1994 & has been associated with this company since 31 years 7 months . was documented.

  • Director Appointment

    Progress on Ranjeet Lachhiram Dave was appointed as a Director was appointed as a Director on 27 Jun 1994 & has been associated with this company since 31 years 7 months . was documented.

  • Company Incorporation

    Shri Lakhavi Drugs P Ltd was registered on 27 Jun 1994 with Roc Mumbai & aged 31 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shri Lakhavi Drugs P Ltd?

The CIN of Shri Lakhavi Drugs P Ltd is U24239MH1994PTC079220.

Where is Shri Lakhavi Drugs P Ltd headquartered?

Shri Lakhavi Drugs P Ltd is headquartered at Devchand Building, 1St Floor, Daulat Nagar, Road No.3, Borivali East,, Mumbai, Maharashtra, 400066.

When was Shri Lakhavi Drugs P Ltd incorporated?

Shri Lakhavi Drugs P Ltd was incorporated on 27 June 1994.

Who are the current directors of Shri Lakhavi Drugs P Ltd?

The current directors of Shri Lakhavi Drugs P Ltd are

What is the primary industry of Shri Lakhavi Drugs P Ltd?

The primary industry of Shri Lakhavi Drugs P Ltd is Chemicals.

Is Shri Lakhavi Drugs P Ltd a listed company?

Shri Lakhavi Drugs P Ltd is unlisted.

What is the capital structure of Shri Lakhavi Drugs P Ltd?

The authorized capital of Shri Lakhavi Drugs P Ltd is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available